GENE ONLINE|News &
Opinion
Blog

Deals
Catalent Scoops Up Fellow CDMO, Metrics, for $475 Million
2022-08-11
Merck Dangles $1.1 Billion For Cerevance To Discover New Targets For Alzheimer’s
2022-08-10
Gilead Sciences Promises $5 million to Combat Monkeypox Public Health Emergency
2022-08-09
Pfizer Acquires Global Blood Therapeutics and its sickle cell disease expertise for $5.4 billion
2022-08-09
GSK Puts Up $100 Million for Mersana’s HER2-Targeting ADC Candidate
2022-08-09
Pfizer Reportedly in Talks of $5 Billion Global Blood Therapeutics Purchase
2022-08-08
Gilead Spends $405 Million In Cash to Acquire MiroBio
2022-08-05
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
Amgen Lays Down $3.7 Billion For ChemoCentryx and its Autoimmune Portfolio
2022-08-04
Roche Dives Deeper into Off-The-Shelf Cell Therapies in Poseida Partnership
2022-08-04
Novo Nordisk Increased Sales by 25% in H1 2022
2022-08-03
A $230M Deal for New Leukemia Drug Awaits FDA
2022-08-03
PerkinElmer Sells Three of its Businesses for $2.45 Billion
2022-08-03
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
Quince Therapeutics Overview for Strategic Growth
2022-08-01
1 14 15 16 17 18 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top